TY - JOUR
T1 - A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery
T2 - combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella (VAVEcpella)
AU - Ushijima, Tomoki
AU - Sonoda, Hiromichi
AU - Tanoue, Yoshihisa
AU - Shiose, Akira
N1 - Funding Information:
The authors would like to thank Editage (http://www.editage.jp) for English language editing. The author(s) received no financial support for the research, authorship, and/or publication of this article.
Publisher Copyright:
© The Author(s) 2020.
PY - 2021/7
Y1 - 2021/7
N2 - Introduction: Ecpella, a combination of veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) and Impella, may result in the differential hypoxia in patients with cardiogenic shock and severe lung dysfunction. Here, we report a solution of this Ecpella-induced unfavorable phenomenon. Case report: A 70-year-old man developed cardiogenic shock from fulminant myocarditis. As we established Ecpella but immediately significant differential hypoxia became apparent, the ECMO configuration was switched from V-A to veno-arteriovenous (V-AV): a combination of V-AV ECMO and Impella, newly termed VAVEcpella, was instituted. The differential hypoxia resolved, and he was successfully weaned from mechanical circulatory support. Discussion and conclusion: VAVEcpella is an effective configuration to resolve Ecpella-induced differential hypoxia and may contribute to restoration of normal cardiac function.
AB - Introduction: Ecpella, a combination of veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) and Impella, may result in the differential hypoxia in patients with cardiogenic shock and severe lung dysfunction. Here, we report a solution of this Ecpella-induced unfavorable phenomenon. Case report: A 70-year-old man developed cardiogenic shock from fulminant myocarditis. As we established Ecpella but immediately significant differential hypoxia became apparent, the ECMO configuration was switched from V-A to veno-arteriovenous (V-AV): a combination of V-AV ECMO and Impella, newly termed VAVEcpella, was instituted. The differential hypoxia resolved, and he was successfully weaned from mechanical circulatory support. Discussion and conclusion: VAVEcpella is an effective configuration to resolve Ecpella-induced differential hypoxia and may contribute to restoration of normal cardiac function.
UR - http://www.scopus.com/inward/record.url?scp=85091002541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091002541&partnerID=8YFLogxK
U2 - 10.1177/0267659120956540
DO - 10.1177/0267659120956540
M3 - Article
C2 - 32928072
AN - SCOPUS:85091002541
VL - 36
SP - 535
EP - 537
JO - Perfusion (United Kingdom)
JF - Perfusion (United Kingdom)
SN - 0267-6591
IS - 5
ER -